Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Regimen of Medical Treatment in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

NCT01925872 is registered in ClinicalTrials.gov with Zhongrong Miao as lead sponsor.

NCT NCT01925872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Regimen of Medical Treatment in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance
Lead sponsor
Zhongrong Miao
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2013
Completion date
May 31, 2015
Enrollment
2,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic cerebrovascular disease